ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 08, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology”; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced its […]